In the study performed by Blondeau et al., the role of TREK-1 appeared minimal in regulation of carotid artery diameter as compared to its role in regulation of basilar arterial tone (1), suggesting that the expression and function of these channels is heterogeneous in the vasculature. This hetereogeneity of function may contribute to findings from both studies demonstrating that deletion of TREK-1 had no effect on blood pressure. Together, these results indicate that although TREK-1 is expressed in the endothelium and may even contribute to maintenance of vasomotor tone in some vascular beds, the role of TREK-1 in regulation of total peripheral resistance is minimal.
TREK-1 is a potential target for the documented protective effects of polyunsaturated fatty acids (PUFA) in the cerebral circulation. The activation of TREK-1 by PUFA coupled with its relative abundance in the cerebral vasculature has prompted several investigations into its role in vasoactive signaling (1-3, 6, 7) . Previous work by Third, their work indicates that if TREK-1 channels are the targets of PUFA, these effects of PUFA must occur through endothelial TREK-1 channels, not channels in the vascular smooth muscle. Intuitively, it would seem that a vasoregulatory role should exist for a channel that is both highly expressed in the endothelium of cerebral vessels and responsive to vasoprotective PUFA. Thus, the findings of Namiranian et al. underline the need to perform future studies in which the activity of TREK-1 channels is specifically evaluated in the endothelium (5) . Without doubt, this constitutes a formidable task, but given the sound and comprehensive experimental approach described in their current manuscript, Namiranian and colleagues are ready to accept this experimental challenge.
